跳至主要内容
临床试验/NCT03836560
NCT03836560已完成不适用

Comparing the Effectiveness of Nicotine Patch With Gum Versus Nicotine Patch Alone in Smoking Cessation in Hong Kong Primary Care Clinics

Hospital Authority, Hong Kong0 个研究点目标入组 560 人开始时间: 2012年12月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
560
主要终点
7-day point-prevalence abstinence rate at 52 weeks after quit date

研究概览

简要总结

The prevalence of cigarette smoking has dropped to 10% in Hong Kong (HK) in 2017, however, smoking still kills 5700 persons per year. Studies suggest that abstinence rates are higher with combined NRT than single NRT, although local data on safety and benefits of combined NRT are lacking.

This is a one-year, two-arm, parallel randomized trial in 20 HK public clinics. The aim is to compare the effectiveness of combined NRT with single NRT among HK Chinese. 560 chronic smokers, who smoked ≥10 cigarettes/day for ≥ 1 year, were randomized to either intervention or usual care.

Intervention group received counseling and nicotine patch & gum. Usual care group received counselling and nicotine patch only. Primary outcome was smoking abstinence rate at 52 weeks. Secondary outcomes included smoking abstinence rate at 4, 12, & 26 weeks. Crude odds ratio (combined NRT vs. single NRT) and p-value were reported from logistic regression without adjustment; for trend analysis, adjusted odds ratio (AOR) and p-value were reported from Generalized Estimating Equation (GEE) (controlling for time). All AORs were adjusted for age, sex, baseline CO and clusters.

详细描述

Background Globally, smoking causes six million deaths a year1. By 2030, if current trends continue, the number of deaths will rise to eight million. According to Hong Kong Thematic Household Survey Reports, although the prevalence of current smokers among aged 15 and over has dropped from 15.3% in 2006 to 10.8% in 2017 in Hong Kong, smoking still kills 5700 persons per year and contributes to 14% of all deaths from non-communicable diseases. Thus, enhancement in smoking cessation would be crucial in improving health all smokers.

Among all pharmacological treatment for smoking cessation, evidences showed that oral treatment such as Varenicline is the most clinically effective smoking cessation medication9. However, there have been concerns about its adverse effect on neuropsychiatric and cardiovascular aspects. Besides, many smokers are reluctant to use it due to fear of its high rate of side effects and being medicalized for smoking cessation. The use of nicotine replacement therapy (NRT) has been largely studied, and, over the last decade, many studies had been carried out to compare the effect of monotherapy with combined nicotine replacement therapy. While the effect of monotherapy had been found to be small in heavy smokers due to significant withdrawal symptoms, combined NRT is believed to provide a stable baseline nicotine level by means of nicotine patch plus intermittent usage of short acting NRT e.g. gums, lozenges or inhalers for withdrawal symptoms. Several studies have shown that combined NRT is associated with lower withdrawal scores and higher 6-month quit rates (26.9 to 36.9%) when compared with monotherapies (19-23%)18-21. Combined NRT has also been shown to be safe as trials of combining various NRTs did not report that combination treatment produced increased adverse events.

In Hong Kong, Hospital Authority is one of the major service providers for smoking cessation. The target recipients of our smoking cessation service are primarily patients attending public general out-patient clinics (GOPCs) for management of chronic illnesses such as hypertension and diabetes mellitus, as well as patients with episodic complaints. Through effective interventions provided in the smoking cessation service, it is aimed that their medical conditions could be further improved. However, as majority of these smokers have moderate or above nicotine dependence, how effective is combined NRT compared to single NRT in this Chinese population is unknown.

Hypothesis:

Combined NRT gives a higher abstinence rate than single NRT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The outcome assessor did not know which arm was interventional/control during the data analysis process.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • current smokers who smoke 10 or more cigarettes a day for at least one year

排除标准

  • unstable angina
  • severe cardiac arrhythmia
  • recent acute myocardial infarction or cerebrovascular accident in preceding 3 months
  • below 18 years old
  • being pregnant or on breast-feeding
  • unable to use gum
  • with a previous history of failure to NRT
  • with a history of hypersensitivity to nicotine

研究组 & 干预措施

Usual group

Active Comparator

Usual group with nicotine patch only:

Usual care involved counseling and 8 weeks of single NRT of nicotine patch. For those smoking 20 or more cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 21mg patches, then 2 weeks of 14mg patches, followed by 2 weeks of 7mg patches. For those smoking 10 to 19 cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 14mg patches, followed by 4 weeks of 7mg patches.

干预措施: Nicotine patch (Drug)

Intervention group

Active Comparator

Nicotine patch and nicotine gum:

Intervention consisted of counseling and 8 weeks of combined NRT of nicotine patch and gum. For those smoking 20 or more cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 21mg patches, then 2 weeks of 14mg patches, followed by 2 weeks of 7mg patches. For those smoking 10 to 19 cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 14mg patches, followed by 4 weeks of 7mg patches. 2mg nicotine gum was used once every 1 to 2 hours when required.

干预措施: Nicotine patch (Drug)

Intervention group

Active Comparator

Nicotine patch and nicotine gum:

Intervention consisted of counseling and 8 weeks of combined NRT of nicotine patch and gum. For those smoking 20 or more cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 21mg patches, then 2 weeks of 14mg patches, followed by 2 weeks of 7mg patches. For those smoking 10 to 19 cigarettes per day before quitting, the NRT patch regimen was 4 weeks of 14mg patches, followed by 4 weeks of 7mg patches. 2mg nicotine gum was used once every 1 to 2 hours when required.

干预措施: Nicotine gum (Drug)

结局指标

主要结局

7-day point-prevalence abstinence rate at 52 weeks after quit date

时间窗: at 52 weeks after the agreed quit date

During initial assessment, patient will set a quit date with the counsellor. At 52 weeks after the quit rate, counsellor will call the patient and confirm his quit status. The status was confirmed by self reporting abstinence rate and exhaled carbon monoxide level

次要结局

  • side effects profiles(up to 1 year)
  • 7-day point-prevalence of abstinence rate at 26 weeks after quit date(at 26 weeks after the agreed quit date)

研究者

发起方
Hospital Authority, Hong Kong
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr Maria Leung

Consultant in Family Medicine

Hospital Authority, Hong Kong

相似试验